(1)

⁶⁸Gallium-DOTANOC (⁶⁸Ga-DOTANOC) positron emission tomography (PET) imaging in Bronchial Carcinoids (BC): multicentre evaluation of its role in clinical practice

ea0046p3 | (1)

Health-related quality of life (HRQoL), anxiety, depression and impulsivity in patients with advanced Gastroenteropancreatic Neuroendocrine Tumours (GEPNETs)

ea0046p4 | (1)

Measurement of urinary 5-hydroxyindole acetic acid: correlation between spot versus 24-hour urine collection

ea0046p5 | (1)

Incidence and characteristics of Ileo-colonic neuroendocrine tumours identified in the UK bowel cancer screening programme

ea0046p6 | (1)

Whole-exome next generation sequencing of sporadic adrenocortical carcinomas - evidence for a proposed adenoma-carcinoma carcinogenesis sequence

ea0046p7 | (1)

Evaluation of quality of life after each cycle in patients treated with Peptide Receptor Radionuclide Therapy (PRRT)

ea0046p8 | (1)

Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies

ea0046p9 | (1)

Whole-exome sequencing (WES) of samples from patients with advanced pancreatic neuroendocrine tumours (pNETs) with exceptional responses vs. poor responders to targeted therapies; a TransNET study

ea0046p10 | (1)

Biomarkers for carcinoid heart disease

ea0046p11 | (1)

Assessing treatment benefit of telotristat etiprate in patients with carcinoid syndrome: Patient exit interviews

ea0046p12 | (1)

Evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells (CTCs) in patients with neuroendocrine tumours (NET)

ea0046p13 | (1)

Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis

ea0046p14 | (1)

Perioperative carcinoid crisis during surgery-who benefits from octreotide?

ea0046p15 | (1)

Low rate of psychological ill health in patients with GEP NETS attending an ENETS Centre of Excellence

ea0046p16 | (1)

Knockdown of Gα15 in BON cell line enhances pancreastatin inhibitory effect on neoplastic proliferation

ea0046p17 | (1)

UK Phase IV, Observational study to assess Quality of Life in patients (pts) with pancreatic neuroendocrine tumours (pNETs) receiving treatment with Everolimus: The “Real-World” OBLIQUE Study

ea0046p18 | (1)

High-grade neuroendocrine tumours of the oesophagus: a single centre experience

ea0046p19 | (1)

Patient outcomes after cardiac surgery for carcinoid heart disease are dependant upon successful cytoreductive multimodal treatment and control of metastatic neuroendocrine disease

ea0046p20 | (1)

Initial experience of a novel technique for endoscopic full thickness resection of rectal neuroendocrine tumours

ea0046p21 | (1)

Efficacy of the combination of Capecitabine and Temozolamide in patients with advanced Pulmonary Carcinoid Tumors: A single institution experience

ea0046p22 | (1)

Multivisceral transplantation and vascularised sentinel forearm flap for a metastatic small bowel neuroendocrine tumour: Update on follow-up

ea0046p23 | (1)

Evaluation of faecal elastase 1 in symptomatic patients with neuroendocrine tumours

ea0046p24 | (1)

Improving outcomes for patients with resectable small bowel NET tumours; 5 year experience from a tertiary centre

ea0046p25 | (1)

Prognostic factors that mandate long term follow up following surgery for appendix neuroendocrine tumours (aNETs)

ea0046p26 | (1)

The use of continuous glucose monitoring to investigate and manage a rare cause of spontaneous hypoglycaemia

ea0046p27 | (1)

Modality to detect pancreatic NETS in MEN1: EUS or MRI?

ea0046p28 | (1)

Outcome of Surgical Resection after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) for Pancreatic Neuroendocrine Neoplasms: a case-matched analysis

ea0046p29 | (1)

Succinate dehydrogenase subunit-B mutation with associated prolactinoma and typical carcinoids

ea0046p30 | (1)

Evaluating the impact of the Specialist Nurse

ea0046p31 | (1)

A single centre analysis of the management of appendiceal neuroendocrine neoplasms (NENs) including goblet cell carcinoids (GCC)

ea0046p32 | (1)

Orbital neuroendocrine tumor metastases: diversity of presentation

ea0046p33 | (1)

A case report of bicaval stents and inferior vena cava valve implantation to control carcinoid symptoms in order to safely allow surgical valve replacement

ea0046p34 | (1)

An exploration of psychological symptoms in vasoactive hormone-secreting neuroendocrine tumours (carcinoid syndrome)

ea0046p35 | (1)

Endocrine Abstracts

UKI NETS 14th National Conference

Poster Presentations

MicroRNAs associated with small bowel neuroendocrine tumours and their metastases

⁶⁸Gallium-DOTANOC (⁶⁸Ga-DOTANOC) positron emission tomography (PET) imaging in Bronchial Carcinoids (BC): multicentre evaluation of its role in clinical practice

Health-related quality of life (HRQoL), anxiety, depression and impulsivity in patients with advanced Gastroenteropancreatic Neuroendocrine Tumours (GEPNETs)

Measurement of urinary 5-hydroxyindole acetic acid: correlation between spot versus 24-hour urine collection

Incidence and characteristics of Ileo-colonic neuroendocrine tumours identified in the UK bowel cancer screening programme

Whole-exome next generation sequencing of sporadic adrenocortical carcinomas - evidence for a proposed adenoma-carcinoma carcinogenesis sequence

Evaluation of quality of life after each cycle in patients treated with Peptide Receptor Radionuclide Therapy (PRRT)

Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies

Whole-exome sequencing (WES) of samples from patients with advanced pancreatic neuroendocrine tumours (pNETs) with exceptional responses vs. poor responders to targeted therapies; a TransNET study

Biomarkers for carcinoid heart disease

Assessing treatment benefit of telotristat etiprate in patients with carcinoid syndrome: Patient exit interviews

Evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells (CTCs) in patients with neuroendocrine tumours (NET)

Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis

Perioperative carcinoid crisis during surgery-who benefits from octreotide?

Low rate of psychological ill health in patients with GEP NETS attending an ENETS Centre of Excellence

Knockdown of Gα15 in BON cell line enhances pancreastatin inhibitory effect on neoplastic proliferation

UK Phase IV, Observational study to assess Quality of Life in patients (pts) with pancreatic neuroendocrine tumours (pNETs) receiving treatment with Everolimus: The “Real-World” OBLIQUE Study

High-grade neuroendocrine tumours of the oesophagus: a single centre experience

Patient outcomes after cardiac surgery for carcinoid heart disease are dependant upon successful cytoreductive multimodal treatment and control of metastatic neuroendocrine disease

Initial experience of a novel technique for endoscopic full thickness resection of rectal neuroendocrine tumours

Efficacy of the combination of Capecitabine and Temozolamide in patients with advanced Pulmonary Carcinoid Tumors: A single institution experience

Multivisceral transplantation and vascularised sentinel forearm flap for a metastatic small bowel neuroendocrine tumour: Update on follow-up

Evaluation of faecal elastase 1 in symptomatic patients with neuroendocrine tumours

Improving outcomes for patients with resectable small bowel NET tumours; 5 year experience from a tertiary centre

Prognostic factors that mandate long term follow up following surgery for appendix neuroendocrine tumours (aNETs)

The use of continuous glucose monitoring to investigate and manage a rare cause of spontaneous hypoglycaemia

Modality to detect pancreatic NETS in MEN1: EUS or MRI?

Outcome of Surgical Resection after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) for Pancreatic Neuroendocrine Neoplasms: a case-matched analysis

Succinate dehydrogenase subunit-B mutation with associated prolactinoma and typical carcinoids

Evaluating the impact of the Specialist Nurse

A single centre analysis of the management of appendiceal neuroendocrine neoplasms (NENs) including goblet cell carcinoids (GCC)

Orbital neuroendocrine tumor metastases: diversity of presentation

A case report of bicaval stents and inferior vena cava valve implantation to control carcinoid symptoms in order to safely allow surgical valve replacement

An exploration of psychological symptoms in vasoactive hormone-secreting neuroendocrine tumours (carcinoid syndrome)

Cardiac metastases from ileal NETs

BiosciAbstracts